Sunitinib Teva

Sunitinib Teva is an oral prescription medication used for treating certain types of cancer. It belongs to a class of drugs known as kinase inhibitors. This product is manufactured by Teva B.V and is available in the EU market.

Sunitinib Teva is primarily used to treat specific cancers, including gastrointestinal stromal tumors and advanced kidney cancer. It is also prescribed for pancreatic neuroendocrine tumors in some cases. This medication works by slowing or stopping the growth of cancer cells. Patients often ask, 'what is Sunitinib used for' to understand its role in treatment plans.

Sunitinib Teva may help reduce tumor size and slow disease progression in eligible patients. Common effects include fatigue, digestive changes, and skin discoloration. Some users report a metallic taste in the mouth or mild nausea. These effects vary by individual and should be monitored by a healthcare provider.

Store Sunitinib Teva at room temperature, away from moisture and heat. Keep the medication in its original packaging until ready to use. Avoid crushing, splitting, or chewing the tablets unless advised by a doctor. Always handle with care and keep out of reach of children and pets.

Sunitinib Teva may interact with other medications, including strong CYP3A4 inhibitors or inducers. Grapefruit products can affect how the drug is processed in the body. Discuss all current medications, supplements, and herbal products with your healthcare provider before starting treatment. Alcohol use should be limited during therapy.